Addition of chemoradiotherapy to palliative chemotherapy in de novo metastatic nasopharyngeal carcinoma: a real-world study.

Cancer Cell Int · 2022 · PMC8788066 · PMID 35073926

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

close to being statistically significantP = 0.052so close (0.05 < p ≤ 0.1)

However, the difference in DPFS between the PCT + CCRT group and the PCT + RT group was close to being statistically significant (median DPFS, 29.4 vs 18.7 months; P = 0.052).

also in 228 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.